Skip to content
Menu

Mizuho Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $22

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Mizuho analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $21 to $22.

Mizuho analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $21 to $22.

Read at benzinga.com